Clinical and Immunological Recovery Trajectories in Severe COVID-19 Survivors: A 12-Month Prospective Follow-Up Study. [PDF]
Strumiliene E +5 more
europepmc +1 more source
Native C3 is activated without proteolytic cleavage by transformation to C3(H<sub>2</sub>O) on phospholipid-scrambled cell membranes. [PDF]
Eikrem D +11 more
europepmc +1 more source
Early Activation of the Complement System After Brain Death in Clinical Kidney Donation and Transplantation. [PDF]
Knijff LWD +7 more
europepmc +1 more source
Aberrant sphingosine-1-phosphate receptor 1 expression on activated naive B cells associated with disease activity and lupus nephritis in systemic lupus erythematosus. [PDF]
Tianpothong P +8 more
europepmc +1 more source
Crystal structures of two isomers of 1-(naphthalen-1-yl)ethanol. [PDF]
Golz C.
europepmc +1 more source
Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics. [PDF]
Rizk DV +5 more
europepmc +1 more source
Microcomputed tomography examination of the cortical and trabecular structures of the cranial cervical spine in dogs and cats. [PDF]
Klotz V +3 more
europepmc +1 more source
Successful Treatment of Bullous Pemphigoid Complicated by Possible Infective Endocarditis With Dupilumab Monotherapy: A Case Report. [PDF]
Kohri N +8 more
europepmc +1 more source
A multi-target drug design method based on target feature fusion. [PDF]
Liu H, Lin X, Hu J, Zhang X.
europepmc +1 more source

